These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24107673)

  • 1. Exercise-induced platelet activation in essential hypertension: have we solved the puzzle?
    Gkaliagkousi E; Gavriilaki E; Nikolaidou B; Douma S
    J Hypertens; 2013 Sep; 31(9):1915-6. PubMed ID: 24107673
    [No Abstract]   [Full Text] [Related]  

  • 2. Exercise-induced platelet activation in essential hypertension: have we solved the puzzle? Reply.
    Kahan T; Schwieler JH; Wallén H; Nussberger J; Hjemdahl P
    J Hypertens; 2013 Sep; 31(9):1917. PubMed ID: 24107674
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet activation during exercise is not attenuated by inhibition of the renin-angiotensin system: the role of physical activity.
    Petidis K; Grammatiki M; Doumas M
    J Hypertens; 2013 Oct; 31(10):2103. PubMed ID: 24107739
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet activation during exercise is not attenuated by inhibition of the renin angiotensin system: the role of physical activity.
    Kahan T; Schwieler JH; Wallén H; Nussberger J; Hjemdahl P
    J Hypertens; 2013 Oct; 31(10):2103-4. PubMed ID: 24107740
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of the renin-angiotensin system does not reduce platelet activity at rest or during stress in hypertension.
    Schwieler JH; Kahan T; Wallén NH; Nussberger J; Hjemdahl P
    J Hypertens; 2013 Aug; 31(8):1676-82. PubMed ID: 23625113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension: are they equivalent?
    Kaplan NM
    J Am Soc Hypertens; 2015 Aug; 9(8):582-3. PubMed ID: 26319536
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitor or Angiotensin receptor blocker use and renal outcomes-reply.
    Hsu CC; Liu JS; Tarng DC
    JAMA Intern Med; 2014 Oct; 174(10):1706-7. PubMed ID: 25285739
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blockers of renin-angiotensin-aldosterone system in the treatment of arterial hypertension: classics versus the modern].
    Kanorskiĭ SG
    Kardiologiia; 2013; 53(10):89-95. PubMed ID: 24645559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use and renal outcomes: prevalent user designs may overestimate benefit.
    Tomlinson L; Smeeth L
    JAMA Intern Med; 2014 Oct; 174(10):1706. PubMed ID: 25285737
    [No Abstract]   [Full Text] [Related]  

  • 10. An ACE in the hole for patients with advanced chronic kidney disease?
    Park M; Hsu CY
    JAMA Intern Med; 2014 Mar; 174(3):355-6. PubMed ID: 24342932
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema.
    Makani H; Bangalore S; Romero J; Wever-Pinzon O; Messerli FH
    Am J Med; 2011 Feb; 124(2):128-35. PubMed ID: 21295192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-Angiotensin system antagonists and mortality in patients with heart failure.
    Fonarow GC; Ahmed A
    JAMA; 2013 Mar; 309(11):1107. PubMed ID: 23512045
    [No Abstract]   [Full Text] [Related]  

  • 13. [Be careful when combining ACE inhibitors and angiotensin receptor blockers].
    Markun S
    Praxis (Bern 1994); 2013 May; 102(11):689-90. PubMed ID: 23692910
    [No Abstract]   [Full Text] [Related]  

  • 14. Renin-Angiotensin system antagonists and mortality in patients with heart failure--reply.
    Lund LH; Benson L
    JAMA; 2013 Mar; 309(11):1107-8. PubMed ID: 23512046
    [No Abstract]   [Full Text] [Related]  

  • 15. The authors reply.
    Sarafidis PA; Ruilope LM
    Kidney Int; 2014 Oct; 86(4):855. PubMed ID: 25265953
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of definitive evidence for the use of renin-angiotensin system antagonists for heart failure with preserved ejection fraction.
    Khalid U; Deswal A
    Evid Based Med; 2013 Dec; 18(6):226-7. PubMed ID: 23585078
    [No Abstract]   [Full Text] [Related]  

  • 17. Of fads, fashion, surrogate endpoints and dual RAS blockade.
    Messerli FH; Staessen JA; Zannad F
    Eur Heart J; 2010 Sep; 31(18):2205-8. PubMed ID: 20685681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renin-angiotensin system antagonists associated with reduced [corrected] mortality in diastolic heart failure].
    Edner M; Lund LH
    Lakartidningen; 2013 Feb 13-19; 110(7):331. PubMed ID: 23513377
    [No Abstract]   [Full Text] [Related]  

  • 19. Heartbeat: Renin-angiotensin system blockade for prevention of cardiovascular disease.
    Otto CM
    Heart; 2017 Sep; 103(17):1305-1307. PubMed ID: 28811285
    [No Abstract]   [Full Text] [Related]  

  • 20. Sodium depletion in patients in clinical trials may account for the increased cardiovascular risk of dual blockade of the renin-angiotensin system.
    Laragh JH; Sealey JE
    BMJ; 2013 Mar; 346():f1685. PubMed ID: 23512453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.